巩膜睫状体光凝术治疗恶性青光眼睫状环阻滞解除后高眼压

目的:探讨经巩膜睫状体光凝治疗恶性青光眼睫状环阻滞解除后高眼压的短期与中期有效性和安全性。方法:回顾性研究。收集2016-10/2019-10恶性青光眼睫状环阻滞解除后眼压仍高的患者14例14眼,采用810nm半导体二极管激光经巩膜睫状体光凝术治疗,随访8.36±5.18mo,观察手术前后最佳矫正视力(BCVA)、眼压及并发症情况。结果:治疗后末次随访眼压13.60±3.50mmHg较术前40.53±7.14mmHg有差异(P<0.05);术后末次随访BCVA与术前比较无差异(P>0.05),所有患者至末次随访时无严重并发症。结论:采用810nm半导体二极管激光经巩膜睫状体光凝术治疗恶性青光眼疗效确切,操作简便,并发症少,可有效降低眼压,且对术后BCVA损害较小。

Clinical observation of high intraocular pressure after the removal of ciliary ring block in the treatment of malignant glaucoma by scleral cyclophotocoagulation

AIM: To investigate the short-term and mid-term effectiveness and safety of transscleral ciliary body photocoagulation in the treatment of high intraocular pressure after the removal of malignant glaucoma ciliary ring block.

METHODS: Retrospective study. A collection of 14 eyes of 14 patients with high intraocular pressure after ciliary ring block was lifted from 2016-10/2019-10 malignant glaucoma were treated with 810nm semiconductor diode laser transscleral ciliary photocoagulation. Follow-up 8.36±5.18mo, observation Best corrected visual acuity(BCVA), intraocular pressure and complications before and after surgery.

RESULTS: The intraocular pressure of 13.60±3.50mmHg at the last follow-up after treatment was different from 40.53±7.14mmHg before operation(P<0.05); there was no difference between the BCVA at the last follow-up postoperative and preoperative(P>0.05). All patients had no difference to the last follow-up and serious complications.

CONCLUSION: The 810nm semiconductor diode laser transscleral ciliary body photocoagulation is effective in the treatment of malignant glaucoma. It is easy to operate, has fewer complications, can effectively reduce intraocular pressure, and has little damage to the best corrected vision after surgery.